US Patent Issued to FLAMEL IRELAND on Nov. 25 for "Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" (French Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,604, issued on Nov. 25, was assigned to FLAMEL IRELAND Ltd. (Dublin).

"Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics" was invented by Jordan Dubow (Lyons, France), Claire Megret (Lyons, France), Herve Guillard (Villeurbanne, France) and Jean-Francois Dubuisson (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof."

The patent was filed on Oct. 14, 2022, under Application No. 17/966,538.

*For further information, including images, charts and tables...